FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
Elevance Health Inc Formerly
EL

Elevance Health Inc Formerly

ELVHealth care

Stock · Data from SEC EDGAR 13F · Held by 18 of 87 tracked investors

$439.95
▼ 1.20%
Famous investorshold 18buying 1selling 0
Price (USD)
$439.95
Market cap
$95.4B
P/E ratio
18.7
Tracked investors holding
18 of 87
Next earnings
–

Elevance Health Inc Formerly at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
69out of 100
  • Valuation74
  • Growth59
  • Profitability37
  • Quality45
  • Debt100
  • Stability96
In its favour

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Sep 202621 Oct 20266.994.66+50%
Jun 202615 Jul 20267.456.18+20.6%
Mar 202622 Apr 202612.5810.68+17.8%
Dec 202528 Jan 20263.333.10+7.4%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+2.73%
1M
+10.47%
3M
+16.49%
YTD
+24.19%
1Y
+28.51%
3Y
-0.34%
5Y
+1.11%
Forward P/E
14.6
Dividend yield
1.55%
52-week low
$274.84
52-week high
$450.69

Chart ELV

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

18
SK
Seth Klarman
Baupost Group
9.11%$493,140,000unchanged
GG
Glenn Greenberg
Brave Warrior Advisors
8.23%$377,790,736▼ -13%
BN
Bill Nygren
Oakmark (Harris Associates)
2.53%$1,904,455,957▲ +2.7%
LR
Larry Robbins
Glenview Capital
0.47%$25,755,831New position
RP
Richard Pzena
Pzena Investment Management
0.25%$86,849,890▲ +2%
TB
Tweedy Browne
Tweedy, Browne Company
0.19%$2,481,646▲ +33.8%
Ns
Norský státní fond
Norges Bank
0.15%$1,531,008,381New position
Šn
Švýcarská národní banka
Swiss National Bank
0.13%$239,610,173▼ -5%
Čn
Česká národní banka
Česká národní banka
0.13%$24,228,152▲ +0.8%
JS
Jim Simons
Renaissance Technologies
0.11%$77,876,980▲ +1,193.1%
JG
Joel Greenblatt
Gotham Asset Management
0.11%$46,023,577▲ +198.9%
IE
Israel Englander
Millennium Management
0.1%$281,369,666▼ -20.8%
CA
Cliff Asness
AQR Capital Management
0.06%$164,408,190▲ +34%
GI
Generali Investments CEE
Generali Investments CEE
0.05%$1,005,498unchanged
KG
Ken Griffin
Citadel Advisors
0.04%$350,526,658▼ -42%
RB
Ron Baron
Baron Capital
0%$1,933,650New position
JY
Jeff Yass
Susquehanna International Group
0%$51,695,359▼ -11.2%
KF
Ken Fisher
Fisher Investments
0%$623,324▼ -12.7%

Frequently asked questions

How much is Elevance Health Inc Formerly (ELV) stock?

Elevance Health Inc Formerly shares trade at $439.95, -1.20% over the last trading day. The price is delayed.

What is the market cap of Elevance Health Inc Formerly?

The market cap of Elevance Health Inc Formerly is about $95.4B and its price-to-earnings ratio (P/E) is 18.7.

Does Elevance Health Inc Formerly pay a dividend?

The dividend yield of Elevance Health Inc Formerly is 1.55% a year. The yield can change with the company's decisions.

How has Elevance Health Inc Formerly stock performed over the last year?

The Elevance Health Inc Formerly share price changed by +28.51% over 12 months and by +1.11% over 5 years.

Which big investors hold Elevance Health Inc Formerly?

According to the latest 13F filings, 18 of 87 tracked investors hold Elevance Health Inc Formerly, for example Seth Klarman, Glenn Greenberg, Bill Nygren.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • ✓It has more cash than debt.
  • ✓Revenue grew 8.3% a year over 3 years.
  • ✓It pays a 1.6% dividend, which takes 29% of earnings.
  • What to watch
    • !Out of 100 USD of revenue, only 2.5 USD is left as net profit.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Fairly cheap

    For 1 USD of annual earnings you pay 18.7 USD. Based on next year's estimates 14.6 USD.

    P/E
    18.7×
    P/S
    0.5×
    EV/EBITDA
    10.3×

    Is the company growing?

    Growing
    22
    23
    24
    25

    Revenue over 3 years grew 8.3% a year. Last year 1.4%.

    Does it make money?

    Weak

    Net margin: 2.5%.

    Is it financially healthy?

    Yes
    Cash
    37.8B USD
    Debt
    30.8B USD
    Free CF
    7.9B USD

    It has more cash than debt.

    Does it pay a dividend?

    Pays
    Yield
    1.55%
    Of earnings
    29%

    Over a year you receive roughly 1.55% of the price per share. The payout is manageable for the company. It has raised the dividend for 9 years in a row.

    What do analysts expect?

    Buy
    Average target
    481.48 USD
    Vs price
    +9%

    21 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    18 of 87

    Among the tracked investors, Seth Klarman, Glenn Greenberg, Bill Nygren and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    18.7×
    Forward P/E
    14.6×
    P/B
    2.1×
    P/S
    0.5×
    PEG
    1.46
    EV/EBITDA
    10.3×
    Gross margin
    26.4%
    Operating margin
    4.2%
    Net margin
    2.5%
    ROE
    11.5%
    ROA
    3.9%
    Debt / equity
    0.7×
    Current ratio
    1.5×
    Revenue growth
    1.4%
    Earnings growth
    17.9%
    Beta
    –
    Dividend
    1.55%
    Payout ratio
    29%